| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 28 | 2024 | 175 | 5.030 |
Why?
|
| Asthma | 22 | 2022 | 1039 | 2.950 |
Why?
|
| Pneumothorax | 9 | 2024 | 51 | 2.690 |
Why?
|
| Pulmonary Emphysema | 8 | 2024 | 43 | 2.280 |
Why?
|
| Lung Neoplasms | 16 | 2024 | 2365 | 1.920 |
Why?
|
| Bronchi | 9 | 2019 | 225 | 1.900 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 5 | 2024 | 12 | 1.880 |
Why?
|
| Solitary Pulmonary Nodule | 3 | 2021 | 139 | 1.660 |
Why?
|
| Pneumonectomy | 8 | 2024 | 217 | 1.640 |
Why?
|
| Catheter Ablation | 7 | 2022 | 345 | 1.460 |
Why?
|
| Lung Diseases | 4 | 2019 | 283 | 1.170 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2024 | 306 | 1.140 |
Why?
|
| Respiratory Tract Fistula | 2 | 2017 | 9 | 0.900 |
Why?
|
| Emphysema | 3 | 2021 | 24 | 0.840 |
Why?
|
| Robotic Surgical Procedures | 3 | 2024 | 368 | 0.740 |
Why?
|
| Fluoroscopy | 2 | 2021 | 129 | 0.710 |
Why?
|
| Pulmonary Medicine | 2 | 2019 | 51 | 0.690 |
Why?
|
| Prostheses and Implants | 3 | 2019 | 123 | 0.650 |
Why?
|
| Humans | 78 | 2024 | 93515 | 0.640 |
Why?
|
| Endosonography | 5 | 2022 | 100 | 0.630 |
Why?
|
| Airway Obstruction | 2 | 2019 | 113 | 0.570 |
Why?
|
| Sarcoidosis | 5 | 2016 | 92 | 0.510 |
Why?
|
| Pleural Diseases | 1 | 2017 | 15 | 0.510 |
Why?
|
| Tracheobronchomalacia | 1 | 2016 | 11 | 0.470 |
Why?
|
| Bronchial Diseases | 1 | 2016 | 12 | 0.470 |
Why?
|
| Laryngostenosis | 1 | 2016 | 18 | 0.470 |
Why?
|
| Radiographic Image Enhancement | 1 | 2018 | 449 | 0.470 |
Why?
|
| Postoperative Complications | 4 | 2024 | 2562 | 0.470 |
Why?
|
| Societies, Medical | 2 | 2019 | 621 | 0.470 |
Why?
|
| Tracheal Stenosis | 1 | 2016 | 26 | 0.470 |
Why?
|
| Bronchial Thermoplasty | 3 | 2021 | 6 | 0.460 |
Why?
|
| Hot Temperature | 1 | 2016 | 218 | 0.450 |
Why?
|
| Treatment Failure | 2 | 2013 | 292 | 0.420 |
Why?
|
| Libraries, Digital | 1 | 2013 | 2 | 0.410 |
Why?
|
| Libraries, Medical | 1 | 2013 | 4 | 0.410 |
Why?
|
| Forced Expiratory Volume | 5 | 2024 | 136 | 0.410 |
Why?
|
| Palliative Care | 1 | 2016 | 269 | 0.400 |
Why?
|
| Lung | 8 | 2024 | 1366 | 0.400 |
Why?
|
| Quality of Life | 9 | 2024 | 1780 | 0.400 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2021 | 1133 | 0.380 |
Why?
|
| Image-Guided Biopsy | 4 | 2024 | 78 | 0.380 |
Why?
|
| Chest Tubes | 3 | 2024 | 21 | 0.380 |
Why?
|
| alpha 1-Antitrypsin | 3 | 2024 | 16 | 0.370 |
Why?
|
| Insurance Coverage | 1 | 2013 | 142 | 0.360 |
Why?
|
| Prospective Studies | 10 | 2024 | 4560 | 0.360 |
Why?
|
| Internet | 1 | 2013 | 337 | 0.340 |
Why?
|
| Echocardiography | 3 | 2024 | 745 | 0.340 |
Why?
|
| Female | 39 | 2024 | 48702 | 0.320 |
Why?
|
| Medicare | 1 | 2013 | 455 | 0.310 |
Why?
|
| Middle Aged | 30 | 2024 | 27573 | 0.300 |
Why?
|
| Genetic Testing | 2 | 2016 | 565 | 0.300 |
Why?
|
| Cholinergic Antagonists | 1 | 2009 | 30 | 0.290 |
Why?
|
| Electromagnetic Phenomena | 3 | 2024 | 17 | 0.290 |
Why?
|
| Treatment Outcome | 14 | 2024 | 9099 | 0.280 |
Why?
|
| Male | 35 | 2024 | 44557 | 0.280 |
Why?
|
| Biopsy | 5 | 2024 | 1175 | 0.270 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2017 | 133 | 0.270 |
Why?
|
| Ablation Techniques | 2 | 2019 | 43 | 0.260 |
Why?
|
| Motivation | 1 | 2010 | 310 | 0.250 |
Why?
|
| Smoking Cessation | 1 | 2010 | 269 | 0.250 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2004 | 232 | 0.240 |
Why?
|
| HLA-G Antigens | 2 | 2017 | 52 | 0.220 |
Why?
|
| DNA Methylation | 2 | 2022 | 697 | 0.220 |
Why?
|
| Pulmonary Atelectasis | 1 | 2024 | 19 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 2585 | 0.220 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 111 | 0.220 |
Why?
|
| Dyspnea | 2 | 2024 | 86 | 0.210 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2004 | 16 | 0.210 |
Why?
|
| Bronchitis, Chronic | 1 | 2023 | 3 | 0.210 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 1546 | 0.210 |
Why?
|
| Ventilators, Mechanical | 1 | 2004 | 43 | 0.200 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 319 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2021 | 580 | 0.190 |
Why?
|
| Hypnotics and Sedatives | 1 | 2004 | 137 | 0.190 |
Why?
|
| Swine | 1 | 2024 | 588 | 0.180 |
Why?
|
| Microbiota | 2 | 2019 | 425 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2015 | 353 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1518 | 0.180 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 754 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 392 | 0.180 |
Why?
|
| Software | 2 | 2018 | 670 | 0.180 |
Why?
|
| Risk Assessment | 5 | 2016 | 2441 | 0.180 |
Why?
|
| Reoperation | 1 | 2024 | 702 | 0.180 |
Why?
|
| Interleukin-33 | 1 | 2021 | 28 | 0.180 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 1173 | 0.170 |
Why?
|
| Disease Progression | 4 | 2023 | 1531 | 0.170 |
Why?
|
| Eosinophils | 2 | 2019 | 194 | 0.170 |
Why?
|
| Anxiety | 1 | 2004 | 337 | 0.170 |
Why?
|
| Adult | 17 | 2022 | 27918 | 0.170 |
Why?
|
| Spirometry | 2 | 2012 | 77 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2024 | 356 | 0.170 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2021 | 107 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 1 | 2024 | 369 | 0.160 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 291 | 0.160 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 2017 | 0.160 |
Why?
|
| Electrocoagulation | 2 | 2019 | 22 | 0.160 |
Why?
|
| Epithelial Cells | 3 | 2021 | 700 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2020 | 109 | 0.160 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 504 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 295 | 0.150 |
Why?
|
| Photochemotherapy | 2 | 2019 | 100 | 0.150 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2019 | 64 | 0.150 |
Why?
|
| Organizational Objectives | 1 | 2019 | 22 | 0.150 |
Why?
|
| Fungi | 1 | 2019 | 67 | 0.140 |
Why?
|
| Drainage | 1 | 2020 | 170 | 0.140 |
Why?
|
| Education | 1 | 2019 | 59 | 0.140 |
Why?
|
| Aged | 14 | 2024 | 20434 | 0.140 |
Why?
|
| Retrospective Studies | 6 | 2024 | 10164 | 0.140 |
Why?
|
| Respiratory System | 1 | 2019 | 117 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2021 | 289 | 0.140 |
Why?
|
| International Cooperation | 1 | 2019 | 133 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 300 | 0.140 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 1917 | 0.140 |
Why?
|
| Th2 Cells | 1 | 2019 | 149 | 0.140 |
Why?
|
| Comorbidity | 3 | 2022 | 1007 | 0.140 |
Why?
|
| Laser Therapy | 2 | 2019 | 151 | 0.140 |
Why?
|
| Proteomics | 1 | 2020 | 264 | 0.140 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2018 | 5 | 0.140 |
Why?
|
| Intraoperative Period | 1 | 2018 | 94 | 0.140 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2020 | 224 | 0.140 |
Why?
|
| Muscle, Smooth | 2 | 2016 | 300 | 0.140 |
Why?
|
| Esophageal Neoplasms | 1 | 2020 | 344 | 0.140 |
Why?
|
| United States | 6 | 2021 | 7622 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 134 | 0.130 |
Why?
|
| Neutrophils | 1 | 2019 | 324 | 0.130 |
Why?
|
| Interleukin-6 | 1 | 2019 | 276 | 0.130 |
Why?
|
| Research | 1 | 2019 | 251 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2022 | 1985 | 0.130 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 308 | 0.130 |
Why?
|
| Pleurodesis | 1 | 2017 | 9 | 0.130 |
Why?
|
| Thoracoscopy | 1 | 2017 | 21 | 0.130 |
Why?
|
| Intensive Care Units | 2 | 2015 | 454 | 0.130 |
Why?
|
| Air | 1 | 2017 | 63 | 0.130 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 555 | 0.120 |
Why?
|
| Accreditation | 1 | 2017 | 73 | 0.120 |
Why?
|
| Mediastinal Diseases | 1 | 2016 | 22 | 0.120 |
Why?
|
| Argon Plasma Coagulation | 1 | 2016 | 6 | 0.120 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 129 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1053 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 449 | 0.120 |
Why?
|
| Granuloma | 1 | 2016 | 64 | 0.120 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2016 | 49 | 0.120 |
Why?
|
| TRPC Cation Channels | 1 | 2015 | 24 | 0.120 |
Why?
|
| Phagosomes | 1 | 2015 | 40 | 0.120 |
Why?
|
| Tracheostomy | 1 | 2016 | 46 | 0.120 |
Why?
|
| Intracellular Membranes | 1 | 2015 | 112 | 0.110 |
Why?
|
| Cryosurgery | 1 | 2016 | 66 | 0.110 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 145 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2016 | 207 | 0.110 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2015 | 17 | 0.110 |
Why?
|
| Brachytherapy | 1 | 2016 | 126 | 0.110 |
Why?
|
| Prednisone | 1 | 2015 | 242 | 0.110 |
Why?
|
| Phenotype | 4 | 2022 | 2544 | 0.110 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 520 | 0.110 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 1001 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2019 | 485 | 0.110 |
Why?
|
| Deglutition Disorders | 1 | 2016 | 126 | 0.110 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2015 | 87 | 0.110 |
Why?
|
| Serum Response Factor | 2 | 2004 | 42 | 0.110 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2014 | 22 | 0.100 |
Why?
|
| Heart Diseases | 1 | 2016 | 257 | 0.100 |
Why?
|
| MEDLINE | 1 | 2013 | 8 | 0.100 |
Why?
|
| Web Browser | 1 | 2013 | 5 | 0.100 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 151 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3476 | 0.100 |
Why?
|
| Prognosis | 5 | 2021 | 3911 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2017 | 960 | 0.100 |
Why?
|
| Databases as Topic | 1 | 2013 | 96 | 0.100 |
Why?
|
| Sex Factors | 1 | 2017 | 1105 | 0.100 |
Why?
|
| Risk Factors | 3 | 2022 | 5899 | 0.100 |
Why?
|
| Thoracic Diseases | 1 | 2013 | 28 | 0.100 |
Why?
|
| Adalimumab | 1 | 2014 | 92 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2016 | 505 | 0.100 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2013 | 11 | 0.100 |
Why?
|
| Disease Management | 1 | 2015 | 358 | 0.100 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2015 | 210 | 0.100 |
Why?
|
| Stents | 1 | 2016 | 409 | 0.100 |
Why?
|
| Electromagnetic Fields | 1 | 2013 | 26 | 0.100 |
Why?
|
| Social Networking | 1 | 2013 | 85 | 0.100 |
Why?
|
| Feasibility Studies | 3 | 2023 | 756 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 425 | 0.090 |
Why?
|
| Time Factors | 5 | 2019 | 5410 | 0.090 |
Why?
|
| Medicine | 1 | 2013 | 95 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 626 | 0.090 |
Why?
|
| Curriculum | 1 | 2017 | 594 | 0.090 |
Why?
|
| Pacemaker, Artificial | 1 | 2013 | 109 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2018 | 2026 | 0.090 |
Why?
|
| Prosthesis Design | 1 | 2013 | 297 | 0.090 |
Why?
|
| Animals | 5 | 2024 | 28155 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2016 | 456 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2022 | 3830 | 0.090 |
Why?
|
| Defibrillators, Implantable | 1 | 2013 | 181 | 0.080 |
Why?
|
| Cytokines | 3 | 2021 | 863 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 417 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 219 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2015 | 970 | 0.080 |
Why?
|
| Smoking Prevention | 1 | 2010 | 46 | 0.080 |
Why?
|
| Respiration Disorders | 1 | 2010 | 42 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 1050 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 1103 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 1660 | 0.070 |
Why?
|
| Opportunistic Infections | 1 | 2009 | 57 | 0.070 |
Why?
|
| Histoplasmosis | 1 | 2009 | 28 | 0.070 |
Why?
|
| Respiratory Function Tests | 3 | 2015 | 155 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 1 | 2009 | 83 | 0.070 |
Why?
|
| Hematoma | 1 | 2009 | 106 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2009 | 203 | 0.070 |
Why?
|
| Cell Line | 3 | 2015 | 2464 | 0.070 |
Why?
|
| Sweden | 1 | 2008 | 45 | 0.070 |
Why?
|
| Psychology | 1 | 2008 | 26 | 0.070 |
Why?
|
| Rats, Inbred WKY | 2 | 2004 | 31 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2009 | 183 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 2484 | 0.060 |
Why?
|
| Europe | 1 | 2008 | 337 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 208 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 163 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2009 | 366 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 7061 | 0.060 |
Why?
|
| Gene Expression | 2 | 2016 | 1301 | 0.060 |
Why?
|
| Genotype | 3 | 2020 | 1866 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2019 | 259 | 0.060 |
Why?
|
| Topotecan | 1 | 2006 | 46 | 0.060 |
Why?
|
| Physicians | 1 | 2013 | 682 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2006 | 72 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 688 | 0.060 |
Why?
|
| Length of Stay | 2 | 2020 | 828 | 0.060 |
Why?
|
| Carcinoma, Small Cell | 1 | 2006 | 115 | 0.060 |
Why?
|
| Smoking | 1 | 2010 | 648 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 985 | 0.060 |
Why?
|
| Proteasome Inhibitors | 1 | 2004 | 52 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 71 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2020 | 630 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 1 | 2006 | 152 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 990 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2004 | 88 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 202 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2004 | 56 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 160 | 0.050 |
Why?
|
| Stroke Volume | 2 | 2016 | 438 | 0.050 |
Why?
|
| Narcotics | 1 | 2004 | 72 | 0.050 |
Why?
|
| Propofol | 1 | 2004 | 95 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 1524 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2004 | 340 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 3054 | 0.050 |
Why?
|
| Cardiac Catheterization | 1 | 2024 | 295 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1931 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 1243 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 674 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 693 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 262 | 0.050 |
Why?
|
| Adult Children | 1 | 2022 | 13 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2022 | 38 | 0.050 |
Why?
|
| Japan | 1 | 2022 | 299 | 0.050 |
Why?
|
| Microwaves | 1 | 2022 | 32 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 1922 | 0.040 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2021 | 20 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 2465 | 0.040 |
Why?
|
| CpG Islands | 1 | 2022 | 168 | 0.040 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2021 | 20 | 0.040 |
Why?
|
| Catheters | 1 | 2022 | 96 | 0.040 |
Why?
|
| Rats | 2 | 2004 | 4072 | 0.040 |
Why?
|
| Mothers | 1 | 2022 | 142 | 0.040 |
Why?
|
| Pain | 1 | 2004 | 414 | 0.040 |
Why?
|
| Mediastinum | 1 | 2021 | 43 | 0.040 |
Why?
|
| Calibration | 1 | 2021 | 106 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2004 | 663 | 0.040 |
Why?
|
| Young Adult | 3 | 2019 | 6930 | 0.040 |
Why?
|
| Incidence | 1 | 2024 | 1701 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2715 | 0.040 |
Why?
|
| Genomics | 2 | 2016 | 848 | 0.040 |
Why?
|
| Inhalation | 1 | 2019 | 34 | 0.040 |
Why?
|
| Contraindications | 1 | 2019 | 67 | 0.040 |
Why?
|
| Cryotherapy | 1 | 2019 | 30 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 328 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 917 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 339 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2020 | 478 | 0.040 |
Why?
|
| Bronchoconstriction | 1 | 2018 | 49 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 962 | 0.030 |
Why?
|
| Chromatin | 1 | 2021 | 440 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 304 | 0.030 |
Why?
|
| Alleles | 1 | 2021 | 1139 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1587 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 342 | 0.030 |
Why?
|
| Prevalence | 2 | 2012 | 1321 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2009 | 295 | 0.030 |
Why?
|
| Patient Selection | 1 | 2021 | 690 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2019 | 702 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 537 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2017 | 148 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2016 | 34 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1713 | 0.030 |
Why?
|
| Itraconazole | 1 | 2016 | 12 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 603 | 0.030 |
Why?
|
| Chicago | 1 | 2020 | 1464 | 0.030 |
Why?
|
| TRPC6 Cation Channel | 1 | 2015 | 5 | 0.030 |
Why?
|
| Diglycerides | 1 | 2015 | 20 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 2015 | 31 | 0.030 |
Why?
|
| Acids | 1 | 2015 | 13 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2015 | 34 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 2303 | 0.030 |
Why?
|
| Algorithms | 1 | 2004 | 1953 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 281 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2016 | 122 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 775 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 920 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 57 | 0.030 |
Why?
|
| Exocytosis | 1 | 2015 | 108 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 91 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 101 | 0.030 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 69 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 2015 | 66 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 308 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2015 | 87 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2015 | 139 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 187 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 1762 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2015 | 378 | 0.030 |
Why?
|
| Weight Loss | 1 | 2016 | 234 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 579 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 163 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 990 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 438 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 691 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2020 | 1264 | 0.020 |
Why?
|
| Ion Channel Gating | 1 | 2015 | 302 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 482 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2013 | 63 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 302 | 0.020 |
Why?
|
| Polysomnography | 1 | 2013 | 153 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 664 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 356 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 90 | 0.020 |
Why?
|
| Publishing | 1 | 2013 | 91 | 0.020 |
Why?
|
| Respiratory Therapy Department, Hospital | 1 | 2012 | 1 | 0.020 |
Why?
|
| Medical Laboratory Personnel | 1 | 2012 | 4 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 413 | 0.020 |
Why?
|
| Bacteria | 1 | 2015 | 509 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 168 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 83 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2017 | 822 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 469 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 988 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 762 | 0.020 |
Why?
|
| Calcium | 1 | 2015 | 1176 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1948 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 1448 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 145 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1910 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2544 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2011 | 172 | 0.020 |
Why?
|
| Dependovirus | 1 | 2009 | 37 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 2009 | 42 | 0.020 |
Why?
|
| Histoplasma | 1 | 2009 | 16 | 0.020 |
Why?
|
| Child | 1 | 2020 | 7355 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1768 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2009 | 189 | 0.020 |
Why?
|
| Cause of Death | 1 | 2009 | 273 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 570 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2009 | 422 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 1395 | 0.020 |
Why?
|
| Radiography | 1 | 2009 | 790 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 2802 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 3502 | 0.010 |
Why?
|
| Dipeptides | 1 | 2004 | 39 | 0.010 |
Why?
|
| Liver | 1 | 2009 | 1210 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 4272 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2004 | 191 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 517 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 12269 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 1721 | 0.010 |
Why?
|